Results 71 to 80 of about 88,938 (144)

Local procedures for axillary hyperhidrosis and osmidrosis: A systematic review of prospective and controlled clinical trials

JEADV Clinical Practice, Volume 3, Issue 4, Page 972-1004, September 2024.
Abstract Axillary hyperhidrosis and osmidrosis are challenging to treat, and neither topical nor systemic drugs have provided optimal treatment outcomes. In the past decades, treatment with botulinum toxin (BTX) has gained status as the gold standard, but it has its limitations both in regard to duration as well as indication for osmidrosis ...
Gabriela L. Grove, Mattias A. S. Henning, Katrine Togsverd‐Bo, Catherine M. DiGiorgio, Mathew M. Avram, Merete Haedersdal   +5 more
wiley   +1 more source

Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review

International Journal of COPD, 2014
Charlotte Suppli UlrikDepartment of Respiratory Medicine, Hvidovre Hospital and University of Copenhagen, Hvidovre, DenmarkBackground and aim: Long-acting bronchodilators are the preferred option for maintenance therapy of patients with chronic ...
Ulrik CS
doaj  

Development and Validation of a Stability-Indicating Chromatographic Method for the Determination of Indacaterol Maleate with Glycopyrronium Bromide in Mixture

, 2019
Introduction: (COPD) Chronic Obstructive Pulmonary Disease is a partially reversible and treatable lung disease, characterized by progressive limitation of airflow. It is one of the main causes of mortality and morbidity worldwide.
Marwa Ahmed Fouad, Sonia Talaat Hassib, Nehal Essam Eldin Mohamed, Hanaa Abdelmenem Hashem   +3 more
core   +1 more source

Beclomethasone Dipropionate, Glycopyrronium (as Bromide), and Formoterol Fumarate Dihydrate (Trimbow)

Reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class.
CDA-AMC
core   +1 more source

Single inhaler with beclometasone, formoterol, and glycopyrronium versus triple therapies in adults with uncontrolled asthma: a systematic review and meta-analysis

Scientific Reports
Recent literature has shown that triple therapy is more effective than dual therapy for individuals with uncontrolled asthma. However, the comparative efficacy between different triple therapies remains unclear.
Fulvio Braido, Ioanna Vlachaki, Georgios F. Nikolaidis, Dimitrios Tzelis, Ifigeneia Barouma, Alessio Piraino, Alessandra Madoni, Nicola Scichilone   +7 more
doaj   +1 more source

Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease

Therapeutic Advances in Respiratory Disease, 2015
The recent Global Initiative for Chronic Obstructive Lung Disease (GOLD) chronic obstructive pulmonary disease (COPD) guidelines consider symptoms and exacerbation history in addition to the degree of airflow obstruction for classifying patients.
K. Suresh Babu, Jaymin B. Morjaria
doaj   +1 more source

Glycopyrronium bromide: clinical efficacy and safety in patients with COPD (a review of clinical trials)

Медицинский совет, 2015
Chronic obstructive pulmonary disease (COPD) is a progressive disease with incompletely reversible airflow obstruction that occurs under the impact of various factors (among which smoking is the key factor).
S. Y. Chikina, S. N. Avdeev
doaj   +1 more source

Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells [PDF]

, 2016
Nowadays, there is a considerable gap in knowledge concerning the mechanism(s) by which long-acting β2-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) interact to induce bronchodilation.
Calzetta, L, Calzetta, Luigino, Cazzola, M, Rogliani, Paola, Ora, Josuel, Facciolo, F, Puxeddu, Ermanno, Luigino Calzetta, Josuel Ora, Paola Rogliani, Cazzola, Mario, Mario Cazzola, Francesco Facciolo, Rogliani, P, Matera, Mg, MATERA, Maria Gabriella, Puxeddu, E, Facciolo, Francesco, Ermanno Puxeddu, Ora, J, Maria Gabriella Matera   +20 more
core   +1 more source

Pharmacoeconomic evaluation of triple beclomethasone/glycopyrronium bromide/formoterol combination in the treatment of patients with moderate and severe chronic obstructive pulmonary disease

Objective : To conduct a pharmacoeconomic evaluation of the triple beclomethasone/formoterol/glycopyrronium fixed-dose combination (FDC) for the treatment of patients ...
V. S. Krysanova, A. D. Ermolaeva, T. N. Ermolaeva, K. A. Kokushkin   +3 more
core   +1 more source

Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial

Respiratory Research, 2011
Background NVA237 is a once-daily dry-powder formulation of the long-acting muscarinic antagonist glycopyrronium bromide in development for the treatment of chronic obstructive pulmonary disease (COPD). The glycopyrronium bromide in COPD airways clinical
D'Urzo Anthony, Ferguson Gary T, van Noord Jan A, Hirata Kazuto, Martin Carmen, Horton Rachael, Lu Yimeng, Banerji Donald, Overend Tim   +8 more
doaj   +1 more source